Zobrazeno 1 - 10
of 91
pro vyhledávání: '"ZHER2 affibody"'
Autor:
Pourshohod, Aminollah, Jamalan, Mostafa, Zeinali, Majid, Ghanemi, Marzieh, kheirollah, Alireza
Publikováno v:
In Journal of Drug Delivery Science and Technology August 2019 52:934-941
Autor:
Nazari M; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran., Radmanesh R; Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Publikováno v:
Avicenna journal of medical biotechnology [Avicenna J Med Biotechnol] 2021 Jul-Sep; Vol. 13 (3), pp. 171.
Autor:
Siavoshinia, Leila1, Jamalan, Mostafa2, Zeinali, Majid3, Pourshohod, Aminollah1, Koushki, Mahdie1, Moradipoodeh, Bahman1, Mohammadzadeh, Ghorban4 mohammadzadeh@ajums.ac.ir
Publikováno v:
Iranian Journal of Pathology. Spring2021, Vol. 16 Issue 2, p109-118. 10p.
Publikováno v:
Journal of Drug Delivery Science and Technology. 52:934-941
Overexpression of human epidermal growth factor receptor 2 (HER2) can be lead to cell transformation and consequently progression of various kinds of malignancies. Therefore, HER2 receptor is not just a specific target for immunotherapy using monoclo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39d1589e9246fe15ba15f76f73d35947
https://doi.org/10.1016/j.jddst.2019.05.039
https://doi.org/10.1016/j.jddst.2019.05.039
Autor:
Mahboobeh Nazari, Ramin Radmanesh
Publikováno v:
Avicenna Journal of Medical Biotechnology
The article abstract is not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27ba3af2936c6a603faac9d479eca71
https://pubmed.ncbi.nlm.nih.gov/34484647
https://pubmed.ncbi.nlm.nih.gov/34484647
Autor:
Jamalan, Mostafa1 jamalan-m@ajums.ac.ir, Siavoshinia, Leila2, Mohammad Ali Ghaffari2, Zeinali, Majid3
Publikováno v:
Iranian Journal of Allergy, Asthma & Immunology. 2018 Supplement, Vol. 17, p107-108. 2p.
Autor:
Lila Siavoshinia, Mostafa Jamalan, Majid Zeinali, Aminollah Pourshohod, Mahdie Koushki, Bahman Moradipoodeh, Ghorban Mohammadzadeh
Publikováno v:
Iranian Journal of Pathology, Vol 16, Iss 2, Pp 109-118 (2020)
Background & objectives: Overexpression of human epidermal growth factor receptor 2 (HER2) causes cell transformation and development of various types of malignancies. Idarubicin is an effective anti-neoplastic drug but specific delivery of it to the
Externí odkaz:
https://doaj.org/article/b27e3cb488244316b8250c4e80b7b120
Autor:
Siavoshinia, Leila1, Jamalan, Mostafa2, Zeinali, Majid3, mohammadzadeh, Ghorban4 mohammadzadeh@ajums.ac.ir
Publikováno v:
Iranian Journal of Allergy, Asthma & Immunology. Oct2019, Vol. 18 Issue 5, p501-510. 10p.
Autor:
Bahman Moradipoodeh, Majid Zeinali, Leila Siavoshinia, Aminollah Pourshohod, Ghorban Mohammadzadeh, Mahdie Koushki, Mostafa Jamalan
Publikováno v:
Iranian Journal of Pathology, Vol 16, Iss 2, Pp 109-118 (2020)
Background & objectives: Overexpression of human epidermal growth factor receptor 2 (HER2) causes cell transformation and development of various types of malignancies. Idarubicin is an effective anti-neoplastic drug but specific delivery of it to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::591ee82de9a2846d7a3fe32482bb9dc8
https://ijp.iranpath.org/article_239970_77351c9e419599a2a56c503337b57117.pdf
https://ijp.iranpath.org/article_239970_77351c9e419599a2a56c503337b57117.pdf
Autor:
Moradipoodeh, Bahman, Jamalan, Mostafa, Zeinali, Majid, Fereidoonnezhad, Masood, Mohammadzadeh, Ghorban
Publikováno v:
Molecular Biology Reports; Sep2020, Vol. 47 Issue 9, p7139-7151, 13p